Home Your basket
• Carcinogenesis of the eth...
   Price 10.50 €
• Intranasal surgery: the r...
   Price 5.50 €
• Invasive cholesteatoma in...
   Price 10.50 €
• An unusual case of intrat...
   Price 5.50 €
• Optimizing vocal efficien...
   Price 8.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Dysphonia and cervical hy...
   Price 5.50 €
• A new tongue plate for us...
   Price 5.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• How I do it: Salivary duc...
   Price 8.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• Management of swallowing ...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Subcutaneous emphysema an...
   Price 5.50 €
• Percutaneous gastrostomy ...
   Price 10.50 €
• Prospective evaluation of...
   Price 10.50 €
• Late metastasis from rena...
   Price 8.50 €
• Bone anchored hearing aid...
   Price 8.50 €
• Vertebro and cranio veino...
   Price 14.00 €
• Management of cervical ce...
   Price 10.50 €
• Migrating esophageal fore...
   Price 5.50 €
• Evaluation of the presenc...
   Price 12.50 €
• Alternative clinical mana...
   Price 10.50 €
• Identification and locali...
   Price 8.50 €
• Stapedotomy and anatomica...
   Price 5.50 €
• Virtual audiovisual talki...
   Price 10.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Prognostic value of mandi...
   Price 10.50 €
• Simple management of the ...
   Price 12.00 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Management of peritonsill...
   Price 5.50 €
• Acceptability of topical ...
   Price 5.50 €
• Scaling properties of the...
   Price 5.50 €
• Paranasal sinus mucoceles...
   Price 14.00 €

Total Order 293.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

OTOLOGY

Usher type I syndrome in children: Genotype/phenotype correlation and cochlear implant benefits


Authors : Blanchet C, Roux A. F, Hamel C, Ben Salah S, Artières F, Faugère V, Uziel A, Mondain M (Montpellier)

Ref. : rev Laryngol Otol Rhinol. 2007;128,3:137-143.

Article published in french
Downloadable PDF document french



Summary : Objective: To assess the benefit of cochlear implant in children presenting an Usher type 1 syndrome (speech understanding, speech production intelligibility, academic performance) and to search any correlation between the phenotype and the genotype in this population. Materials and methods: Retrospective case series analysis about 13 implanted Usher type I children. Cochlear implantation was performed from 1995 to 2005. Our population was divided in three groups: group 1 (implantation between 1 and 3 years of age); group 2 (implantation between 4 and 7 years of age) and group 3 (implantation between 14 and 17 years of age). Postoperative speech perception, speech production intelligibility and education settings were evaluated. Results: Molecular genetic analysis was performed in 11 patients and pathogenic mutations were identified in all cases: (mutation in myosin 7A gene in 5 cases; mutation in cadherin 23 gene in 6 cases). Four new mutations 2 in the MYO7A gene and 2 in the CDH23 gene never reported before were found. Walking delay and hearing level were not statistically correlated with the genotype abnormalities found. The speech discrimination skills, the speech production intelligibility and the academic performance were better in the group 1 children than the group 2 children after cochlear implantation. All the children of group 1 but one were in mainstreaming education. Specific language impairment was identified in two children of group 1. The group 3 children could not achieve open-set perceptive tasks after implantation - only closed-set word test can be done and their speech production remained unintelligible after cochlear implantation. Conclusion: Molecular analysis of Usher type I syndrome can ascertain the diagnosis in spite of the genetic heterogeneity. In this study, clinical symptoms weren’t correlated with genotypic mutations. Speech discrimination skills, speech production quality, and academic performance were correlated with the age at implant.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE